Suspended NA INTERVENTIONAL NCT00184847

Adenosine Receptors Influence Ischemia-Reperfusion Injury

Adenosine Receptor Involvement in Acute Ischemic Preconditioning of the Vascular Endothelium

Sponsor: Radboud University Medical Center

Interventions acetylcholine adenosine caffeine three 5-minute periods of forearm ischemia twenty minutes of forearm ischemia

Updated 6 times since 2017 Last updated: Mar 27, 2008 Started: Mar 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Suspended

This trial was suspended. No reason was provided.

Listed as NCT00184847, this NA trial focuses on Ischemia-Reperfusion Injury and remains suspended. Sponsored by Radboud University Medical Center, it has been updated 6 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Suspended NA
Jul 2024 — Sep 2024 [monthly]

Suspended NA
Mar 2022 — Jul 2024 [monthly]

Suspended NA
Jan 2021 — Mar 2022 [monthly]

Suspended NA
Jun 2018 — Jan 2021 [monthly]

Suspended NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Suspended NA

First recorded

Mar 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Radboud University Medical Center

Data source: Radboud University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nijmegen, Netherlands